Abstract
Background: Patients with chronic thromboembolic pulmonary hypertension (CTEPH) still experience reduced exercise capacity despite pulmonary endarterectomy (PEA). Exercise training improves the exercise capacity and quality of life (QoL) in patients with PH, but data on the effects of exercise training on these patients are scarce. The aim of this meta-analysis and systematic review was to evaluate the effectiveness and safety of exercise training in CTEPH after PEA.
Methods: We searched the relevant literature published before January 2020 for the systematic review and meta-analysis using the PubMed, EMBASE, and Cochrane Library databases. The primary outcome was a change in the 6-min walking distance (6 MWD). We also assessed the effect of exercise on the peak oxygen uptake (VO2) or peak VO2/kg, oxygen uptake anaerobic threshold, workload, oxygen pulse, hemodynamics, arterial blood gases, oxygen saturation, N-terminal pro-brain-type natriuretic peptide (NT-proBNP), quality of life (QoL) and pulmonary function tests.
Results: We included 4 studies with 208 exercise-training participants. In the pooled analysis, short-term exercise training can improve the 6 MWD of 58.89 m (95% CI: 46.26–71.52 m, P < 0.0001). There was a significant increase in the peak VO2/kg or peak VO2 after exercise training (3.15 ml/min/kg, 95% CI: 0.82–5.48, P = 0.008; 292.69 ml/min, 95% CI: 24.62–560.75, P = 0.032, respectively). After exercise training, the maximal workload and O2 pulse significantly improved. Three months of exercise training increased the right ventricular ejection fraction by 3.53% (95% CI: 6.31–11.94, P < 0.00001, I2 = 0) independently of PEA surgery. In addition, NT-proBNP plasma levels significantly improved with exercise training after PEA [weighted mean difference (WMD): −524.79 ng/L, 95% CI: 705.16 to −344.42, P < 0.0001, I2 = 0]. The partial pressure of oxygen and pH improved progressively over 12 weeks of exercise training (WMD: 4 mmHg, 95% CI: 1.01–8.33, P = 0.01; WMD: 0.03, 95% CI: 0.02–0.04, P < 0.0001, respectively). Subscales of the QoL measured by the SF-36 questionnaire had also improved. In addition, exercise training was well-tolerated with a low dropout rate, and no major adverse events occurred during exercise training.
Conclusion: Exercise training may be associated with a significant improvement in the exercise capacity and QoL among CTEPH patients after PEA and was proven to be safe. However, more large-scale multicentre studies are needed to confirm the effectiveness and safety of exercise training in CTEPH patients after PEA.
PROSPERO registration number:CRD42021235275.
Introduction
Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by stenosis and/or occlusion of pulmonary arteries caused by organized thrombus (1). Early diagnosis and suitable treatment are critical because CTEPH has a high rate of mortality and right-side heart failure (2). Pulmonary endarterectomy (PEA) is a proven curative treatment for operable CTEPH (3, 4). PEA surgery is recommended as the first-line therapy for operable CTEPH patients (ClassI, evidence C) (5, 6). However, some patients still suffer limited exercise capacity despite PEA (7), especially when their pulmonary hemodynamics do not normalize (8, 9). An improvement in exercise tolerance, physical function, and the ability to cope with daily living should be targets during the comprehensive management of these patients (10).
Rehabilitation programmes, including aerobic exercise training, have strong evidence of effectiveness in improving the exercise capacity, dyspnoea, and health-related quality of life (QoL) in different etiologies of pulmonary hypertension (PH) (11–17). Exercise training has also improved muscular and right ventricular function, QoL and pulmonary hemodynamics in idiopathic pulmonary arterial hypertension (PAH), PAH associated with connective tissue diseases and inoperable CTEPH (11–16, 18–20).
Exercise training has improved the exercise capacity for up to 3 months in patients with CTEPH after PEA, independent of the post-surgery hemodynamic response (17, 21–23). However, the evidence of the effect of exercise training on patients with CTEPH after PEA is limited.
Therefore, we performed the meta-analysis and systematic review to assess the efficacy and safety of an exercise training program in CTEPH patients after PEA.
Methods and Analysis
Data Sources and Search Strategy
We designed the study according to the PRISMA statement (Supplementary Table 1) (24). We searched the PubMed, EMBASE, and the Cochrane Collaboration databases using the key words “exercise training,” “chronic thromboembolic pulmonary hypertension,” “pulmonary endarterectomy,” and “rehabilitation” to identify studies that evaluated the efficacy and safety of exercise training for CTEPH patients after PEA surgery. Our search included articles published from the database beginning up to January 2020. The search was limited to human studies and English language articles.
Study Selection
We included five observational studies comparing the effectiveness of exercise training in CTEPH patients after PEA. The inclusion criteria were (1) patients were diagnosed with CTEPH and (2) the patients underwent exercise training after PEA. We excluded studies if they were conference abstracts, case reports, reviews, letters, or editorials.
Data Extraction
Two independent reviewers (Y-L. Z, R.J) performed the literature search, data extraction, and methodological grading. Disagreements were resolved by consensus. We extracted the information of each study, such as the author, year of publication, demographic characteristics, nature of the study, hemodynamics, and pre- and post-exercise intervention results.
Outcomes
The primary outcome was a change in the 6-min walking distance (6 MWD). The secondary outcomes were as follows:
Changes in exercise tolerance by cardiopulmonary exercise testing (CPET): oxygen consumption at peak exercise (peak VO2 and peak VO2/kg), oxygen uptake anaerobic threshold (VO2 at AT), and workload;
Changes in cardiac function by CPET: oxygen pulse, resting and peak heart rate (HR), and resting and peak oxygen saturation;
Changes in pulmonary hemodynamics by right heart catheterization: right atrial pressure (RAP), mean pulmonary artery pressure (mPAP), pulmonary vascular resistance (PVR), pulmonary capillary wedge pressure (PCWP), transpulmonary gradient (TPG), systemic vascular resistance (SVR), total pulmonary resistance (TPR), cardiac output (CO), cardiac index (CI) and right ventricular ejection fraction (RVEF).
Changes in the resting and peak exercise systolic pulmonary arterial pressure (sPAP) by echocardiography;
Changes in N-terminal pro-brain-type natriuretic peptide (NT-proBNP);
Changes in arterial blood gases: pH, oxygen partial pressure (PaO2), and partial pressure of carbon dioxide (PaCO2);
Changes in QoL scales assessed by the SF-36 questionnaire;
Changes in echocardiography, including the resting and peak systolic pulmonary pressure (sPAP);
Changes in pulmonary function tests: forced vital capacity (FVC) and forced expiratory volume at 1 second (FEV1).
Methodological Quality
We used the NIH quality assessment tool to assess the quality of pre-post interventional studies (25). Due to the insufficient number of research articles, publication bias could not be assessed.
Data Synthesis and Statistical Analysis
We conducted meta-analyses for comparisons when two or more studies reported the same outcome. Continuous values are presented as the mean ± SD and analyzed using weighted mean differences (WMDs). We used random-effect models to quantitatively synthesize the evidence and to calculate the summary estimates. Pooled analysis was calculated using fixed-effect models, and random-effect models were applied in cases of significant heterogeneity.
Certain studies reported continuous variables in the form of interquartile ranges or 95% confidence intervals (CI) other than the SD and needed to be converted into SDs. Cases in which converted SDs could not be obtained were excluded. We considered P < 0.05 as significant.
Statistical analysis was performed using Stata version 15 software (Stata Corp., College Station, Texas) and RevMan 5.4 (The Cochrane Collaboration, Copenhagen, Oxford, UK).
Results
Characteristics of the Studies
We retrieved 73 articles for more detailed analysis after 68 initial articles were identified by the search and included 4 studies in our systematic review (Figure 1). There were four pre-post interventional studies, encompassing 208 exercise-training participants between 2012 and 2020 (17, 21–23). All studies used a supervised exercise training programme combined with aerobic exercise (treadmill or bicycle Ergometer) and resistance training. One study was performed at an outpatient rehabilitation center, while three studies were performed in-hospital for the first few weeks followed by home-based exercise training. All training participants underwent low workload aerobic exercise training with some form of resistance and respiratory training. The exercise intensity was titrated at 50–70% of the peak exercise capacity. The characteristics of all included studies are presented in Table 1.
Figure 1
Table 1
| References | No. of patients | Exercise training intervention | Duration and time interval between PEA and the exercise programme | Primary endpoint | Results |
|---|---|---|---|---|---|
| Nagel et al. (17) | n = 45; Female:16; Age: 61 ± 15 years | • In the Rehabilitation Clinic (first 3 weeks): Interval bicycle ergometer, walking, respiratory training (low workloads, 5 days/week, a minimum of 1.5 h/day), single muscle groups (low weights). • Training at home (for 12 weeks): Bicycle ergometer (≥ 30 min/day at 5 days a week). • Psychological support and mental training. | 3 weeks; 15 weeks. Time interval: not described | 6 MWD; CPET variables; stress Doppler echocardiography; HR; blood pressure; Borg dyspnoea index; WHO-FC; SF-36; NT-proBNP; gas exchange | 6 MWD↑; SF-36 scores for physical functioning and vitality↑; peak VO2↑; peak VO2/kg↑; workload↑; an increase of maximal HR↑; NT-proBNP↓; WHO-FC(-). |
| Inagaki et al. (23) | n = 8; Age: 64 ± 12 years | In-hospital each week (40–60 min) and home-based programme, including: • Lower-limb endurance training (walking exercises, a cycle ergometer at 60% of the target HR) • Lower and upper limb strength training • Respiratory exercises • Education | 12 weeks Time interval: not described | Echocardiography; BNP; exercise capacity; dyspnoea severity and the functional status; pulmonary function; peripheral muscle force; physical activity. | 6 MWD↑; TDI scores↑; QF↑; Ex↑; SGRQ scores↑; No change in MRC scores, BDI scores, HRR1, and WHO-FC. |
| La Rovere et al. (21) | Group 1 = 84, Age: 60.4 ± 13.8 years, Female: 6; Group 2 = 26, Age: 57.9 ± 13.1 years, Female: 31. | Daily sessions of: • Incremental exercise training (30 min, at 50–70% of the maximal load); • Abdominal, upper, and lower limb muscle activities including lifting progressively increasing light weights (0.30–0.50 kg), and shoulder and full arm circling; • Education; • Nutritional programmes and psychosocial counseling. | 3 months Time interval: not described | 6 MWD; pulse oximetric oxygen saturation, lung function tests; arterial blood gases; hemodynamics. | PAP↓; TPG↓; RVEF↑; PVR↓; PaO2↑; pH↓; No changes in RAP, PCWP, CO, CI, SVR, PVR,TPR, PaCO2, FEV1,% predicted, FVC, % predicted, and FEV1/FVC, % predicted*. |
| Nagel et al. (22) | n = 45; Female: 22 Age: 57.6 ± 12.4 years. | • In the rehabilitation clinic (first 3 weeks): Interval bicycle ergometer, walking, respiratory training (low workloads, 5 days/week, a minimum of 1.5 h/day), single muscle groups (low weights). • Training at home (for 19 weeks): Bicycle ergometer (≥ 15 min/day at 5 days a week). • Psychological support and mental training | 3 weeks; 19 weeks. Time interval: 3.3 ± 0.9 (median 3.1) weeks | WHO-FC; 6 MWD; BDI scores; echocardiography; lung function; blood gas; SF-36; CPET with stress echocardiography. | 6 MWD↑; SF-36 scores for physical functioning and vitality↑; peak VO2↑; peak VO2/kg↑; workload↑; NT-proBNP↓; RA area↓; RV area↓; sPAP↓; TAPSE↑; left ventricular eccentricity index↓; tissue Doppler imaging s RV free wall↑; oxygen pulse↑; EqCO2↓; BDI↓; HR↓; peak HR↓; O2 at AT↑. |
Characteristics of all included studies.
VE, ventilation; VO2, oxygen consumption; VCO2, carbon dioxide output; WHO-FC, WHO functional class; NT-proBNP, N-terminal pro-brain natriuretic peptide; 6 MWD, 6-minute walking distance; TRPG, tricuspid regurgitation pressure gradient; sPAP, systolic pulmonary arterial pressure; BNP, brain natriuretic peptide; MRC, Medical Research Council dyspnoea grade; BDI, dyspnoea index; TDI, Transition dyspnoea index. QF, quadriceps force; HF, handgrip force; HHR1, heart rate recovery during the first minute; HR, heart rate; NRADL, Nagasaki University Respiratory ADL Questionnaire; SGRQ, St. George's Respiratory Questionnaire; Ex, amount of exercise; PAP, pulmonary artery pressure; PCWP, pulmonary capillary wedge pressure; TPG, transpulmonary gradient; CO, cardiac output; RVEF, right ventricular ejection fraction; SVR, systemic vascular resistance; PVR, pulmonary vascular resistance; TPR, transpulmonary resistance; FVC, forced vital capacity; FEV1, forced expiratory volume at 1 second; RA, right atrial; RV, right ventricular; TAPSE, tricuspid annular plane systolic excursion; SaO2, oxygen saturation; EqCO2:respiratory equivalent for CO2.
COMPARED integrated two groups with 3-month vs. after surgery (before rehabilitation).
Quality Assessment
The quality assessment of the pre-post interventional studies had a detailed description. All included studies had a clearly stated study question, prespecified eligibility/selection criteria, CTEPH patient's representative in the real world, clearly defined intervention and outcome variables, and low rate of loss to follow-up (Supplemental Table 2).
Six-Minute Walking Distances
In Christian Nagel's study (22), the 6 MWD significantly improved by 55.31 ± 53.67 m (95% CI: 39.19–71.43, P < 0.0001) and 65.11 ± 63.96 m (95% CI: 43.14–87.09, P < 0.0001) with 3- or 19-week exercise training after PEA in patients with CTEPH, respectively. By pooling analysis, short-term exercise training can improve the 6 MWD of 58.89 m (95% CI: 46.26–71.52 m, P < 0.0001) (Figure 2). Ekkehard Grünig evaluated the effects of exercise training in patients with inoperable or residual CTEPH in a prospective study (17). The 6 MWD significantly improved by 71 ± 70 m after 15 weeks among 35 inoperable or residual CTEPH patients (P = 0.001). Jiro Terada also evaluated the changes in the 6 MWD after a 12-week exercise training programme in 8 inoperable or residual CTEPH patients (23). After completion of the pulmonary rehabilitation programme, the 6 MWD significantly improved by 33.3 ± 25.1 m compared with the baseline (P < 0.01). However, we could not extract information on residual CTEPH from the studies of Ekkehard Grünig and Jiro Terada.
Figure 2
Cardiopulmonary Exercise Testing
Patients performed a gradually increasing work rate CPET to maximal tolerance on an electromagnetically braked cycle ergometer in the upright position. The peak VO2, peak VO2/kg, VO2 at AT, peak workload, oxygen pulse, HR and oxygen saturation were evaluated to assess the CPET capacity.
Regarding exercise tolerance, Christian Nagel's study (22) was included to analyse the peak VO2, peak VO2/kg, VO2 at AT and peak workload by pooling analysis.
There was a significant increase in the peak VO2/kg or peak VO2 after exercise training (3.15 ml/min/kg, 95% CI: 0.82–5.48, P = 0.008; 292.69 ml/min, 95% CI: 24.62–560.75, P = 0.032, respectively). However, there were no significant increases in VO2 at AT (136.32 ml/min, 95% CI: −66.78–339.41, P = 0.19). After exercise training, the max workload during exercise had significantly improved (26.69 Watt, 95% CI: 9.41–43.98, P = 0.002) (Table 2).
Table 2
| Variable (22) | WMD (95% CI) | % Weight | P-value |
|---|---|---|---|
| Exercise tolerance | |||
| Peak VO2/kg | 3.15 (0.82, 5.48) | 53.78 | 0.008 |
| after 3 weeks | 1.99 (1.48, 2.50) | 16.26 | |
| after 12/15 weeks | 4.37 (3.48, 5.26) | 16.17 | |
| Peak VO2 | 292.69 (24.62, 560.75) | 3.45 | 0.032 |
| after 3 weeks | 158.50 (122.50,194.50) | 1.08 | |
| after 12/15 weeks | 432.09 (349.76, 514.42) | 0.22 | |
| VO2 at AT | 136.32 (−66.78, 339.41) | 1.11 | 0.188 |
| after 3 weeks | 37.07 (−34.72, 108.86) | 0.29 | |
| after 12/15 weeks | 244.50 (133.71, 355.29) | 0.12 | |
| Workload max | 26.69 (9.41, 43.98) | 41.65 | 0.002 |
| after 3 weeks | 18.18 (13.05, 23.31) | 12.69 | |
| after 12/15 weeks | 35.83 (27.53, 44.13) | 9.33 | |
| Cardiac function | |||
| O2 pulse | 1.55 (0.40, 2.70) | 33.09 | 0.008 |
| after 3 weeks | 0.98 (0.48, 1.48) | 11.41 | |
| after 12/15 weeks | 2.15 (1.50, 2.80) | 10.97 | |
| HR rest | −2.70 (−7.75, 2.35) | 10.8 | 0.295 |
| after 3 weeks | −0.36 (−3.16, 2.44) | 4.09 | |
| after 12/15 weeks | −5.54 (−9.76, −1.32) | 2.21 | |
| HR max | 10.41 (−0.66, 21.48) | 4.66 | 0.065 |
| after 3 weeks | 4.95 (−0.20, 10.10) | 1.58 | |
| after12/15 weeks | 16.25 (9.69, 22.81) | 1.03 | |
| SaO2 rest | 0.55 (0.02, 1.08) | 31.10 | 0.043 |
| after 3 weeks | 0.39 (−0.24, 1.02) | 11.02 | |
| after 12/15 weeks | 0.94 (−0.05, 1.93) | 9.72 | |
| SaO2 max | 1.18 (−0.18, 2.54) | 20.35 | 0.088 |
| after 3 weeks | 0.57 (−1.31, 2.45) | 6.41 | |
| after 12/15weeks | 1.85 (−0.11, 3.81) | 6.16 | |
Changes in cardiopulmonary exercise testing after exercise training in CTEPH patients with PEA.
SaO2, oxygen saturation; PEA, pulmonary endarterectomy; HR, heart rate; Oxygen consumption, O2; WMD, weighted mean difference.
With regard to cardiac function, we pooled the study of Christian Nagel to analyse the oxygen pulse, resting and peak HR, and resting and peak oxygen saturation (22). By exercise training, the O2 pulse and oxygen saturation had significantly improved (1.55, 95% CI: 0.40–2.70, P = 0.008; 0.55%, 95% CI: 0.02–1.08, P = 0.043), with a tread of an improved of maximal HR of 10.41 bpm (0.66, 95% CI: −0.66 to 21.48, P = 0.065) and maximal saturation of 1.18% (95% CI: −0.18 to 2.54, P = 0.088) during exercise (Table 2). In Ekkehard Grünig's study (17), among patients with inoperable or residual CTEPH after PEA, the peak oxygen consumption, maximal workload and maximal HR had improved (Supplementary Table 3).
Effect of PEA on Hemodynamic Measurements
In Nicolino Ambrosino's study (21), CTEPH patients were divided into Group 1 (n = 84) and Group 2 (n = 26) according to the post-surgery hemodynamic response. Group 1 patients met at least one of the following criteria: (1) mPAP ≤ 25 mm Hg; (2) ≥50% reduction in mPAP; and (3) ≥70% reduction in PVR. Group 2 included patients who did not meet any of these criteria. In this study, we combined the mean and SD of the two groups before PEA, after PEA and after exercise training.
CTEPH patients had a decreased mPAP of 18.10 mmHg, PCWP of 1.46 mmHg, TPG of 20.01 mmHg, SVR of 548.87 dynes/cm−5, PVR of 528.61 dynes/cm−5, and TPR of 532 dynes/cm−5 after PEA surgery. PEA surgery increased the CO, CI and RVEF. However, the RAP remained unchanged (Table 3).
Table 3
| Variables (21) | Pulmonary hemodynamic measurements after PEA before rehabilitation | Pulmonary hemodynamic measurements with 3 months of exercise training after PEA | ||
|---|---|---|---|---|
| MD (95% CI) | P-value | MD (95% CI) | P-value | |
| RAP, mmHg | −0.04 (−2.26, 2.18) | 0.97 | −0.14 (−0.94, 0.66) | 0.74 |
| mPAP, mmHg | −18.10 (−29.35, −6.84) | 0.002 | −0.18 (−5.60, 5.25) | 0.95 |
| PCWP, mmHg | 1.46 (0.04, 2.87) | 0.04 | −0.24 (−1.10, 0.63) | 0.59 |
| TPG, mmHg | −20.01 (−29.98, −10.03) | <0.0001 | 0.34 (−4.36, 5.05) | 0.89 |
| CO, L/min | 0.92 (0.59, 1.25) | <0.00001 | 0.20 (−0.10, 0.50) | 0.19 |
| CI, L/min/m2 | 0.49 (0.20, 0.77) | 0.0009 | 0.10 (−0.04, 0.24) | 0.17 |
| RVEF, % | 9.12 (6.31, 11.94) | <0.00001 | 3.53 (1.11, 5.95) | 0.004 |
| SVR, dyn·s·cm−5 | −548.87 (−687.29, −410.44) | <0.00001 | 92.20 (−15.24, 199.63) | 0.09 |
| PVR, dyn·s·cm−5 | −538.61 (−744.64, −332.59) | <0.00001 | 1.19 (−78.37, 80.75) | 0.98 |
| TPR, dyn·s·cm−5 | −532.00 (−773.86, −290.13) | <0.0001 | −10.72 (−103.32, 81.87) | 0.82 |
Forest plots of pulmonary hemodynamic measurements.
RAP, right atrial pressure; mPAP, mean pulmonary arterial pressure; PCWP, pulmonary capillary wedge pressure; TPG, transpulmonary gradient; CO, cardiac output; CI, cardiac index; RVEF, right ventricular ejection fraction; SVR, systemic vascular resistance; PVR, pulmonary vascular resistance; TPR, transpulmonary resistance; PEA, pulmonary endarterectomy; MD, mean difference.
Effect of Exercise Training After PEA on Hemodynamic Measurements
Table 3 shows the changes in hemodynamics from immediately after the surgery (before rehabilitation) to 3 months after the exercise training. Three months of exercise training increased the RVEF by 3.53% (95% CI: 6.31–11.94, P < 0.00001, I2 = 0). However, 3 months of exercise training did not influence the RAP, mPAP, PCWP, TPG, CO, CI, SVR, PVR or TPR (Table 3).
NT-proBNP, Arterial Blood Gases, Echocardiography, and Pulmonary Function Test
By pooling analysis in Christian Nagel's study (22), we found that the NT-proBNP plasma levels had continuously decreased by 524.79 ng/L (95% CI: −705.16 to −344.42, P < 0.0001, I2 = 0) when CTEPH patients underwent 3–19 weeks of exercise training after PEA surgery (Table 4).
Table 4
| Variables | WMD (95% CI) | I2 (%) | P-value |
|---|---|---|---|
| NT-proBNP, ng/L (22) | −524.79 (−705.16, −344.42) | 0 | <0.0001 |
| Changes after 3 weeks | −482.30 (−698.90, −269.70) | ||
| Changes after 19 weeks | −622.21 (−955.09, −289.33) | ||
| Arterial blood gases(21) | |||
| From before surgery to after surgery (before rehabilitation) | |||
| PaO2, mmHg | 9.30 (6.04, 12.55) | 0 | <0.00001 |
| PaCO2, mmHg | 1.72 (0.54, 2.89) | 48 | 0.004 |
| pH | 0.01 (0, 0.02) | 0 | 0.04 |
| From after surgery (before rehabilitation) to 3 months rehabilitation | |||
| PaO2, mmHg | 4.67 (1.01, 8.33) | 0 | 0.01 |
| PaCO2, mmHg | 0.90 (−0.28, 2.08) | 0 | 0.13 |
| pH | −0.03 (−0.04, −0.02) | 0 | <0.00001 |
| Echocardiography(22) | |||
| After 3 weeks | −1.20 (−3.14, 0.74) | 0 | 0.225 |
| sPAP rest | −1.29 (−3.55, 0.97) | ||
| sPAP max | −0.95 (−4.74, 2.84) | ||
| After 19 weeks | 7.42 (3.87, 10.97) | 0 | <0.0001 |
| sPAP rest | 6.37 (2.23, 10.51) | ||
| sPAP max | 10.35 (3.44, 17.26) | ||
| Pulmonary function test(21) | |||
| FVC % predicted | 4.10 (−0.63, 8.83) | 0 | 0.09 |
| FEV1 % predicted | 3.30 (−2.72, 9.32) | 0 | 0.28 |
| FEV1/FVC % predicted | 2.70 (−1.13, 6.53) | 0 | 0.17 |
The effect of exercise training on NT-proBNP, arterial blood gases, echocardiography, and pulmonary function test in patients with CTEPH after PEA.
NT-proBNP, N-terminal pro-brain-type natriuretic peptide; PEA, pulmonary endarterectomy; PaO2, oxygen partial pressure; PaCO2, partial pressure of carbon dioxide; sPAP, systolic pulmonary arterial pressure; FVC, forced vital capacity; FEV1, forced expiratory volume at 1 second; WMD, weighted mean difference.
By combining the mean and SD of the two groups in Nicolino Ambrosino's study (21), PEA surgery significantly improved the PaO2 by 9.30 mmHg, PaCO2 by 1.72 mmHg and pH by 0.01 (Table 4). Three months of exercise training after PEA surgery further improved the PaO2 and the pH (WMD: 4 mmHg, 95% CI: 1.01–8.33, P = 0.01; WMD: 0.03, 95% CI: 0.02–0.04, P < 0.0001, respectively), but not the PaCO2 (Table 4).
In Christian Nagel's study (22), the resting sPAP or maximal sPAP during exercise training improved with the extension of rehabilitation (Table 4). Ekkehard Grünig's study (17) and Jiro Terada's study (23) also assessed the sPAP by echocardiography. In the two interventional studies (17, 23), there were no significant improvements in resting sPAP or maximal sPAP. We cannot conduct quantitative meta-analysis of the sPAP in the above three studies because Ekkehard Grünig's and Jiro Terada's studies included some inoperable CTEPH patients.
In addition, the right atrial and right ventricular areas, tricuspid annular plane systolic excursion (TAPSE), left ventricular eccentricity index, pulmonary artery diameter, and tissue Doppler imaging of the RV free wall, as assessed by echocardiography, improved by varying degrees with exercise training (22).
In Christian Nagel's study (22), neither the FVC% predicted, FEV1% predicted nor FEV1/FVC% predicted improved after 12 weeks of exercise training after PEA.
Quality of Life
Christian Nagel's study described the QoL change after exercise training in CTEPH patients after PEA (22). The subscales for physical function (WMD: 29.78 points, 95% CI: 15.26–44.30, P < 0.0001), physical role functioning (WMD: 29.76 points, 95% CI: 13.68–45.84, P < 0.0001), bodily pain (WMD: 11.05 points, 95% CI: 2.02–20.08, P = 0.017), and social role functioning (WMD: 13.13 points, 95% CI: 2.25–24.01, P = 0.018) improved during the 19-week exercise training after PEA (Figure 3). However, physical function, general health perception, physical role functioning, vitality, emotional role and mental health had not significantly improved (Figure 3).
Figure 3
Safety of Exercise Training
In most of the included studies, exercise training was well-tolerated with an overall dropout rate of 5%. Approximately 0.9% of the training patients experienced syncope or palpitations, half of which were related to exercise training (2.2%). Furthermore, during exercise training, no major adverse events, such as symptom progression, right heart failure, or death, occurred among participants (Table 5).
Table 5
| References | Total no. of exercise training participants | Exercise training related adverse events |
|---|---|---|
| Nagel et al. (17) | 45 | Syncope in one patient; Herpes zoster infection in one patient. |
| Shamseer et al. (24) | 8 | Low blood pressure and tachycardia in one patient |
| La Rovere et al. (21) | 110 | None |
| Nagel et al. (22) | 45 | None |
Adverse effects reported in the included studies.
Discussion
The principal finding of our study is that exercise training significantly improves exercise capacity and cardiorespiratory fitness among CTEPH patients after PEA. There was also a significant reduction in the NT-proBNP and an improvement in the arterial blood gases. Furthermore, exercise training was well-tolerated with significant improvements in the QoL.
Our study has important clinical implications. Exercise rehabilitation has been actively discouraged in PAH patients because of the fear that it would worsen symptoms and negatively impact cardiac function. However, recently, with evidence of exercise rehabilitation in PH, supervised rehabilitation, including exercise training, has been recommended for patients with PH (Class I,A) (26). The 2019 ERS statement on exercise training and rehabilitation acknowledges the strong evidence of benefits from exercise training in PH (27). Exercise training has shown beneficial effects as an add-on to PAH-specific drug therapies among CTEPH patients (17). Current guidelines recommend PEA as a potentially curative first-choice treatment that is superior to medical therapies in inoperable CTEPH patients (28, 29). Our study findings provide comprehensive evidence to support the efficacy and safety of exercise training in patients with CTEPH after PEA.
In Angelo G. Corsico's study, most of the CTEPH patients recovered good exercise tolerance (30). However, ~40% continue to suffer from the limitation of moderate intensity exercise (30). Exercise limitation 12 months after PEA is characterized by multifactorial etiologies involving lower RVEF, CI and pulmonary function test abnormalities (FVC, FEV1/FVC, and single breath carbon monoxide diffusing capacity).
Exercise Training on the Exercise Capacity and QoL
As the primary endpoint, the 6 MWD, peakVO2 or peakVO2/kg demonstrated significant increases in many studies (11, 19, 28, 29, 31). In our study, we observed significant improvements in exercise tolerance, shown as the 6 MWD, peak VO2 or peak VO2/kg, after exercise training.
Exercise training performed in different etiologies of PH improved not only the exercise capacity but also different aspects of the QoL, as shown in several studies (16–20, 27, 29).
From the ERS statement of summarized outcomes of the QoL in many studies (27), bodily pain and general health perception always have no significant differences. Bodily pain, general health perception and social role functioning were significantly improved in our study. Our study may indicate that exercise rehabilitation after PEA may be more effective in improving bodily pain, general health perception and social role functioning.
In addition, our study found that exercise training can improve the exercise capacity independent of the effect of the PEA surgery response.
In this systematic review, only Christian Nagel's study described the time interval between the PEA and the initiation of the exercise programme (22). Patients underwent exercise training 3.3 ± 0.9 (median 3.1) weeks after PEA. Other studies did not describe the time interval. There is little information about the acute and chronic effects of PEA on the exercise capacity and ventilatory efficiency in patients with CTEPH. N Nagaya's study examined the changes in exercise training and ventilatory efficiency as indicated by the peak VO2 and the VE/VCO2 slope after PEA (32). After PEA, the VE/VCO2 slope decreased greatly from baseline (before surgery) to the early phase (1 month) and reached a steady level thereafter. In contrast, they noted a continued increase in the peakVO2 from the early to the late phase (4 months) after surgery as well as from the baseline to the early phase (32). Surprisingly, the increase in the peak VO2 after surgery did not correlate with the decrease in the PVR. The peak VO2 is influenced not only by CO during exercise but also by oxygen extraction in skeletal muscles and vasodilatation of the nutrient arterioles within working skeletal muscles (33). From another point of view, exercise training can improve skeletal muscle oxygen extraction and can continue to improve exercise tolerance in CTEPH patients independent of decreased PVR after PEA.
Hemodynamics, Echocardiography, and Cardiac Function
Thus far, most exercise training trials published in PH have focused on changes in the exercise capacity. Only one prospective, randomized, controlled trial was designed to systematically evaluate changes during rest and exercise by the invasive measurement of hemodynamics as secondary endpoints (31). Altogether, the study revealed significant increases in CI at rest or during peak exercise and decreases in mPAP and PVR at rest in the training group among 73 PAH or inoperable CTEPH patients. In Nicolino Ambrosino's study (21), CTEPH patients were divided into two groups, with and without “good” surgery hemodynamic response. We integrated the data of the two groups into one group before PEA, after PEA and after exercise training. Among the 110 CTEPH patients, they had decreased mPAP, PCWP, TPG, SVR, PVR, and TPR after PEA surgery. PEA surgery increased the CO, CI, and RVEF, respectively. After PEA, CTEPH patients continued exercise training and underwent evaluation at the 3-month follow-up. Compared with before training but after PEA, exercise training can increase the RVEF (Δ3.53%) but not other hemodynamics, such as the RAP, mPAP, PCWP, TPG, CO, CI, SVR, PVR, and TPR.
Most exercise training studies involved performing echocardiography to estimate sPAP and right ventricular functional variables (20). Although not all individual studies revealed significant improvements in echocardiographic parameters (31), the pooled analysis showed that exercise training had a significantly decreased resting sPAP of 3.7 mmHg. Our pooled analysis showed sPAP was assessed by echocardiography at 3 weeks or 12/15 weeks regardless of the resting sPAP or peak sPAP. In our study, we did not pool the analysis of right heart areas because only Christian Nagel's study assessed this outcome (22).
With regard to the cardiac function assessed by CPET (17, 22), the oxygen pulse had a trend toward an increase at 3 weeks. However, regardless of whether at rest or max, neither the HR nor oxygen saturation changed. Meanwhile, NT-proBNP plasma levels continued to decrease with 12 or 15 weeks of exercise training after PEA.
Interestingly, our pooled analysis showed the arterial blood gases at the end of the post-PEA 3-month exercise training significantly improved, similar to the improvement observed at the end of the PEA.
Limitations
Our study had several limitations. First, we found only a few studies that had assessed the safety and efficacy of exercise training in CTEPH patients after PEA. Studies of early rehabilitation after PEA are scarce, and our study may provide some insights into the safety, tolerability and clinical effects of CTEPH undertaking early exercise training programme after PEA. Second, most studies have not evaluated clinical endpoints, such as right heart failure and mortality. Therefore, we also cannot analyse the impact of exercise training on clinical endpoints. Third, it is difficult to assess the sustainability of the effects of exercise training interventions among CTEPH patients after PEA. Fourth, all included studies were single center and had a shorter duration of follow-up. In the future, multicentre randomized controlled trials with longer follow-up durations are needed to further verify the benefits of exercise training on CTEPH patients after PEA in the real world. Finally, as with all meta-analyses, selection bias cannot be completely excluded. Publication bias could not be assessed because of the insufficient number of research articles.
Conclusions
The findings of this systematic review and meta-analysis suggest that exercise training may be associated with a significant improvement in the exercise capacity and QoL among CTEPH patients after PEA and proved to be safe. Exercise training also improves arterial blood gases and NT-proBNP. However, additional large-scale and multicentre studies are needed to better evaluate the long-term effectiveness and safety of exercise training in CTEPH after PEA.
Statements
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Author contributions
LW, PY, and RJ contributed to conception and design of the study. Y-LZ, Q-HZ, and RZ organized the database. JH, S-GG, and C-JL performed the statistical analysis. H-LQ wrote the first draft of the manuscript. J-ML, Y-LZ, and PY wrote sections of the manuscript. All authors contributed to manuscript revision, read, and approved the submitted version.
Funding
The work was funded by the Program of National Natural Science Foundation of China (81700045, 81870042, and 82000059) and the Department Development Fund of Shanghai Pulmonary Hospital (201906-0314).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcvm.2021.664984/full#supplementary-material
References
1.
MemonHALinCHGuhaA. Chronic thromboembolic pulmonary hypertension: pearls and pitfalls of diagnosis. Methodist Debakey Cardiovasc J. (2016) 12:199–204. 10.14797/mdcj-12-4-199
2.
NishimuraRTanabeNSugiuraTShigetaAJujoTSekineAet al. Improved survival in medically treated chronic thromboembolic pulmonary hypertension. Circ J. (2013) 77:2110–7. 10.1253/circj.CJ-12-1391
3.
MadaniMM. Surgical treatment of chronic thromboembolic pulmonary hypertension: pulmonary thromboendarterectomy. Methodist Debakey Cardiovasc J. (2016) 12:213–8. 10.14797/mdcj-12-4-213
4.
KimNHDelcroixMJaisXMadaniMMMatsubaraHMayerEet al. Chronic thromboembolic pulmonary hypertension. Eur Respirat J. (2019) 53:1801915. 10.1183/13993003.01915-2018
5.
McLaughlinVVArcherSLBadeschDBBarstRJFarberHWLindnerJRet al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. (2009) 119:2250–94. 10.1161/CIRCULATIONAHA.109.192230
6.
FukudaKDateHDoiSFukumotoYFukushimaNHatanoMet al. Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017). Circ J. (2019) 83:842–945. 10.1253/circj.CJ-66-0158
7.
FukuiSOgoTGotoYUedaJTsujiASandaYet al. Exercise intolerance and ventilatory inefficiency improve early after balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Int J Cardiol. (2015) 180:66–8. 10.1016/j.ijcard.2014.11.187
8.
ReesinkHJvan der PlasMNVerheyNEvan SteenwijkRPKloekJJBresserP. Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg. (2007) 133:510–6. 10.1016/j.jtcvs.2006.10.020
9.
BondermanDMartischnigAMVonbankKNikfardjamMMeyerBHeinzGet al. Right ventricular load at exercise is a cause of persistent exercise limitation in patients with normal resting pulmonary vascular resistance after pulmonary endarterectomy. Chest. (2011) 139:122–7. 10.1378/chest.10-0348
10.
GraarupJFerrariPHowardLS. Patient engagement and self-management in pulmonary arterial hypertension. Eur Respir Rev. (2016) 25:399–407. 10.1183/16000617.0078-2016
11.
MerelesDEhlkenNKreuscherSGhofraniSHoeperMMHalankMet al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. (2006) 114:1482–9. 10.1161/CIRCULATIONAHA.106.618397
12.
de ManFSHandokoMLGroepenhoffHvan't Hul AJAbbinkJKoppersRJet al. Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. Eur Respirat J. (2009) 34:669–75. 10.1183/09031936.00027909
13.
FoxBDKassirerMWeissIRavivYPeledNShitritDet al. Ambulatory rehabilitation improves exercise capacity in patients with pulmonary hypertension. J Cardiac Failure. (2011) 17:196–200. 10.1016/j.cardfail.2010.10.004
14.
GrunigELichtblauMEhlkenNGhofraniHAReichenbergerFStaehlerGet al. Safety and efficacy of exercise training in various forms of pulmonary hypertension. Eur Respirat J. (2012) 40:84–92. 10.1183/09031936.00123711
15.
ChanLChinLMKKennedyMWoolstenhulmeJGNathanSDWeinsteinAAet al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest. (2013) 143:333–43. 10.1378/chest.12-0993
16.
GrunigEMaierFEhlkenNFischerCLichtblauMBlankNet al. Exercise training in pulmonary arterial hypertension associated with connective tissue diseases. Arthritis Res Ther. (2012) 14:R148. 10.1186/ar3883
17.
NagelCPrangeFGuthSHerbJEhlkenNFischerCet al. Exercise training improves exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertension. PLoS ONE. (2012) 7:e41603. 10.1371/journal.pone.0041603
18.
WeinsteinAAChinLMKeyserREKennedyMNathanSDWoolstenhulmeJGet al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respirat Med. (2013) 107:778–84. 10.1016/j.rmed.2013.02.006
19.
YuanPYuanXTSunXYPudasainiBLiuJMHuQH. Exercise training for pulmonary hypertension: a systematic review and meta-analysis. Int J Cardiol. (2015) 178:142–6. 10.1016/j.ijcard.2014.10.161
20.
PandeyAGargSKhungerMGargSKumbhaniDJChinKMet al. Efficacy and safety of exercise training in chronic pulmonary hypertension: systematic review and meta-analysis. Circul Heart Failure. (2015) 8:1032–43. 10.1161/CIRCHEARTFAILURE.115.002130
21.
La RovereMTPinnaGDPinMBruschiCCallegariGZanottiEet al. Exercise training after pulmonary endarterectomy for patients with chronic thromboembolic pulmonary hypertension. Respiration. (2019) 97:234–41. 10.1159/000492754
22.
NagelCNasereddinMBenjaminNEgenlaufBHarutyunovaSEichstaedtCAet al. Supervised exercise training in patients with chronic thromboembolic pulmonary hypertension as early follow-up treatment after pulmonary endarterectomy: a prospective cohort study. Respiration. (2020) 99:577–88. 10.1159/000508754
23.
InagakiTTeradaJTanabeNKawataNKasaiHSugiuraTet al. Home-based pulmonary rehabilitation in patients with inoperable or residual chronic thromboembolic pulmonary hypertension: a preliminary study. Respir Investig. (2014) 52:357–64. 10.1016/j.resinv.2014.07.002
24.
ShamseerLMoherDClarkeMGhersiDLiberatiAPetticrewMet al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. (2015) 350:g7647. 10.1136/bmj.g7647
25.
MaLLWangYYYangZHHuangDWengHZengXT. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?Mil Med Res. (2020) 7:7. 10.1186/s40779-020-00238-8
26.
GalieNCorrisPAFrostAGirgisREGrantonJJingZCet al. Updated treatment algorithm of pulmonary arterial hypertension. J Am College Cardiol. (2013) 62(Suppl. 25):D60–72. 10.1016/j.jacc.2013.06.032
27.
GrunigEEichstaedtCBarberaJABenjaminNBlancoIBossoneEet al. ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension. Eur Respirat J. (2019) 53:180033210.1183/13993003.00332-2018
28.
DelcroixMLangIPepke-ZabaJJansaPD'ArminiAMSnijderRet al. Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective Registry. Circulation. (2016) 133:859–71. 10.1161/CIRCULATIONAHA.115.016522
29.
GalieNHumbertMVachieryJLGibbsSLangITorbickiAet al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. (2015) 46:903–75. 10.1093/eurheartj/ehv317
30.
EufingerH. [Indication and technic of thrombectomy in the therapy of thrombosis]. Med Klin. (1975) 70:856–60.
31.
EhlkenNLichtblauMKloseHWeidenhammerJFischerCNechwatalRet al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. Eur Heart J. (2016) 37:35–44. 10.1093/eurheartj/ehv337
32.
IwaseTNagayaNAndoMSatohTSakamakiFKyotaniSet al. Acute and chronic effects of surgical thromboendarterectomy on exercise capacity and ventilatory efficiency in patients with chronic thromboembolic pulmonary hypertension. Heart. (2001) 86:188–92. 10.1136/heart.86.2.188
33.
RileyMSPorszaszJEngelenMPShapiroSMBrundageBHWassermanK. Responses to constant work rate bicycle ergometry exercise in primary pulmonary hypertension: the effect of inhaled nitric oxide. J Am College Cardiol. (2000) 36:547–56. 10.1016/S0735-1097(00)00727-0
Summary
Keywords
pulmonary endarterectomy, pulmonary hypertension, exercise intolerance, cardiorespiratory fitness, exercise training
Citation
Zhao Y-L, Yuan P, Zhao Q-H, Gong S-G, Zhang R, He J, Luo C-J, Qiu H-L, Liu J-M, Wang L and Jiang R (2021) Comparative Effectiveness of Exercise Training for Patients With Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy: A Systematic Review and Meta-Analysis. Front. Cardiovasc. Med. 8:664984. doi: 10.3389/fcvm.2021.664984
Received
06 February 2021
Accepted
24 May 2021
Published
17 June 2021
Volume
8 - 2021
Edited by
Dachun Xu, Tongji University, China
Reviewed by
Marco Post, St. Antonius Hospital, Netherlands; Qian He, Second Military Medical University, China
Updates
Copyright
© 2021 Zhao, Yuan, Zhao, Gong, Zhang, He, Luo, Qiu, Liu, Wang and Jiang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Rong Jiang listening39@163.comLan Wang wanglan198212@163.com
This article was submitted to Heart Failure and Transplantation, a section of the journal Frontiers in Cardiovascular Medicine
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.